ACC/AHA classification of coronary lesions reflects medical resource use in current percutaneous coronary

Kenichi Sakakura1, Junya Ako, Hiroshi Wada

  • 1Division of Cardiovascular Medicine, Department of Integrated Medicine I, Jichi Medical University Saitama Medical Center, Omiya, Saitama, Japan. ZXH03005@nifty.ne.jp

Insights

The American College of Cardiology/American Heart Association (ACC/AHA) lesion classification system effectively predicts medical resource utilization during percutaneous coronary interventions (PCI). More complex lesions (Type C) require significantly more resources than simpler ones (Type A).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Economics

Background:

  • The current utility of the American College of Cardiology/American Heart Association (ACC/AHA) classification system for coronary lesions in reflecting medical resource consumption during percutaneous coronary interventions (PCI) remains unclear.
  • Understanding this relationship is crucial for optimizing resource allocation and cost-effectiveness in cardiovascular procedures.

Purpose of the Study:

  • To investigate the association between the ACC/AHA classification of coronary artery lesions and the utilization of medical resources during PCI.
  • To determine if lesion complexity, as defined by the ACC/AHA system, correlates with procedural costs, contrast volume, and fluoroscopy time.

Main Methods:

  • A retrospective analysis of 447 coronary artery lesions treated with PCI between January 1, 2009, and December 31, 2009, was conducted.
  • Lesions were categorized into Type A, B1, B2, and C according to ACC/AHA criteria.
  • Total PCI costs, contrast volumes, and fluoroscopy times were compared across these lesion types.

Main Results:

  • A significant correlation was observed between ACC/AHA lesion type and medical resource utilization (P < 0.0001).
  • Total PCI costs, contrast volumes, and fluoroscopy times increased progressively from Type A to Type C lesions.
  • Specifically, average PCI costs ranged from $7,262 for Type A to $13,243 for Type C lesions.

Conclusions:

  • The ACC/AHA lesion classification system serves as a reliable indicator of medical resource consumption in contemporary PCI.
  • Complex coronary lesions (Type C) are associated with substantially higher costs, contrast use, and fluoroscopy times compared to simpler lesions (Type A).
  • This stratification has implications for procedural planning, cost-effectiveness analyses, and resource management in interventional cardiology.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...